Quarterly report pursuant to Section 13 or 15(d)

Prepaid Expenses and Other Current Assets (Tables)

v3.21.2
Prepaid Expenses and Other Current Assets (Tables)
6 Months Ended
Jun. 30, 2021
Prepaid Expense And Other Assets Current [Abstract]  
Summary of Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consist of the following:

 

 

 

June 30,

2021

 

 

December 31,

2020

 

Refundable FDA filing fee (1)

 

$

 

 

$

2,876

 

Short-term deposits

 

 

2,288

 

 

 

2,360

 

Prepaid insurance

 

 

1,344

 

 

 

415

 

Research and development tax credit receivable

 

 

677

 

 

 

801

 

Interest receivable

 

 

261

 

 

 

 

Other prepaid assets

 

 

196

 

 

 

231

 

Prepaid research and development expenses

 

 

69

 

 

 

157

 

Value added tax receivable

 

 

56

 

 

 

64

 

Deferred financing expenses

 

 

37

 

 

 

 

Total

 

$

4,928

 

 

$

6,904

 

(1) FDA filing fee refund of $2,876 was received in January 2021